Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanotubes, Carbon | 11 | 2017 | 87 | 3.180 |
Why?
|
| Cell Movement | 7 | 2025 | 640 | 1.490 |
Why?
|
| MicroRNAs | 3 | 2025 | 501 | 1.220 |
Why?
|
| Endothelium, Vascular | 3 | 2013 | 261 | 1.000 |
Why?
|
| Reactive Oxygen Species | 6 | 2025 | 518 | 0.880 |
Why?
|
| Hydrogen Peroxide | 1 | 2025 | 193 | 0.860 |
Why?
|
| Fabaceae | 1 | 2024 | 29 | 0.840 |
Why?
|
| Cell Membrane Permeability | 3 | 2016 | 57 | 0.840 |
Why?
|
| Endothelial Cells | 2 | 2013 | 324 | 0.620 |
Why?
|
| Vibration | 1 | 2018 | 23 | 0.600 |
Why?
|
| Peripheral Nerves | 1 | 2018 | 14 | 0.600 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2018 | 21 | 0.590 |
Why?
|
| Oxidative Stress | 2 | 2018 | 990 | 0.580 |
Why?
|
| Nanoparticles | 2 | 2016 | 449 | 0.570 |
Why?
|
| Thrombospondin 1 | 1 | 2017 | 23 | 0.520 |
Why?
|
| Nanofibers | 1 | 2016 | 14 | 0.490 |
Why?
|
| Mutagens | 2 | 2018 | 76 | 0.490 |
Why?
|
| Respiratory System | 1 | 2016 | 31 | 0.490 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 235 | 0.440 |
Why?
|
| Comet Assay | 2 | 2012 | 77 | 0.440 |
Why?
|
| Mesenteric Arteries | 1 | 2013 | 20 | 0.410 |
Why?
|
| Inflammation | 1 | 2018 | 729 | 0.410 |
Why?
|
| NF-kappa B | 3 | 2016 | 355 | 0.400 |
Why?
|
| Lung Neoplasms | 3 | 2013 | 479 | 0.400 |
Why?
|
| Asbestos | 2 | 2010 | 57 | 0.380 |
Why?
|
| Gene Expression | 2 | 2017 | 692 | 0.380 |
Why?
|
| Environmental Pollutants | 4 | 2018 | 198 | 0.370 |
Why?
|
| Transcription Factor AP-1 | 2 | 2010 | 31 | 0.370 |
Why?
|
| Toxicology | 1 | 2012 | 8 | 0.370 |
Why?
|
| Microvessels | 1 | 2012 | 31 | 0.360 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2010 | 136 | 0.350 |
Why?
|
| Lung | 2 | 2012 | 484 | 0.350 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2013 | 130 | 0.350 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2013 | 188 | 0.330 |
Why?
|
| Drug Carriers | 1 | 2012 | 169 | 0.330 |
Why?
|
| Carcinogens | 2 | 2010 | 126 | 0.320 |
Why?
|
| Neoplasms, Mesothelial | 1 | 2008 | 1 | 0.300 |
Why?
|
| Humans | 16 | 2025 | 42163 | 0.250 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 297 | 0.250 |
Why?
|
| Signal Transduction | 5 | 2017 | 2111 | 0.240 |
Why?
|
| Animals | 8 | 2024 | 16695 | 0.220 |
Why?
|
| Medicine, African Traditional | 1 | 2024 | 8 | 0.220 |
Why?
|
| Plants, Medicinal | 1 | 2024 | 60 | 0.210 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2012 | 58 | 0.180 |
Why?
|
| Cell Line | 3 | 2016 | 1416 | 0.180 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2018 | 1737 | 0.180 |
Why?
|
| Plant Extracts | 1 | 2024 | 303 | 0.170 |
Why?
|
| Chemokine CCL2 | 2 | 2012 | 95 | 0.170 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 1554 | 0.170 |
Why?
|
| Transforming Growth Factor beta | 2 | 2016 | 214 | 0.160 |
Why?
|
| Tail | 1 | 2018 | 5 | 0.150 |
Why?
|
| Sensory Thresholds | 1 | 2018 | 13 | 0.150 |
Why?
|
| Arsenates | 1 | 2018 | 26 | 0.150 |
Why?
|
| Carcinogens, Environmental | 1 | 2018 | 35 | 0.150 |
Why?
|
| Ganglia, Spinal | 1 | 2018 | 41 | 0.140 |
Why?
|
| Interleukin-1beta | 1 | 2018 | 74 | 0.140 |
Why?
|
| Occupational Diseases | 1 | 2018 | 53 | 0.140 |
Why?
|
| Arsenites | 1 | 2018 | 54 | 0.140 |
Why?
|
| Spinal Cord | 1 | 2018 | 109 | 0.140 |
Why?
|
| Risk Assessment | 2 | 2012 | 845 | 0.140 |
Why?
|
| DNA | 2 | 2012 | 594 | 0.140 |
Why?
|
| Cell Size | 1 | 2017 | 46 | 0.130 |
Why?
|
| DNA Damage | 2 | 2010 | 358 | 0.130 |
Why?
|
| Male | 7 | 2018 | 22779 | 0.130 |
Why?
|
| Collagen Type III | 1 | 2016 | 9 | 0.120 |
Why?
|
| Matrix Metalloproteinases | 1 | 2016 | 49 | 0.120 |
Why?
|
| Inhalation Exposure | 2 | 2013 | 44 | 0.120 |
Why?
|
| Wound Healing | 1 | 2016 | 82 | 0.120 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2013 | 160 | 0.110 |
Why?
|
| Rats | 2 | 2013 | 3701 | 0.110 |
Why?
|
| Diethylhexyl Phthalate | 1 | 2014 | 4 | 0.110 |
Why?
|
| Calcium-Binding Proteins | 1 | 2014 | 80 | 0.100 |
Why?
|
| Myography | 1 | 2013 | 2 | 0.100 |
Why?
|
| Computational Biology | 2 | 2013 | 324 | 0.100 |
Why?
|
| Amidohydrolases | 1 | 2013 | 12 | 0.100 |
Why?
|
| Biomedical Research | 1 | 2018 | 467 | 0.100 |
Why?
|
| Nephrectomy | 1 | 2013 | 29 | 0.100 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2013 | 11 | 0.100 |
Why?
|
| Vasodilator Agents | 1 | 2013 | 55 | 0.100 |
Why?
|
| Prognosis | 2 | 2013 | 850 | 0.100 |
Why?
|
| Acetylcholine | 1 | 2013 | 76 | 0.100 |
Why?
|
| Glioblastoma | 1 | 2014 | 69 | 0.100 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2013 | 74 | 0.100 |
Why?
|
| Pulmonary Fibrosis | 1 | 2013 | 38 | 0.100 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2013 | 32 | 0.100 |
Why?
|
| GTPase-Activating Proteins | 1 | 2013 | 29 | 0.100 |
Why?
|
| Vasodilation | 1 | 2013 | 64 | 0.100 |
Why?
|
| Arginine | 1 | 2013 | 75 | 0.100 |
Why?
|
| DNA Helicases | 1 | 2013 | 46 | 0.100 |
Why?
|
| Epithelial Cells | 2 | 2013 | 426 | 0.100 |
Why?
|
| Respiratory Mucosa | 1 | 2013 | 41 | 0.100 |
Why?
|
| Cells, Cultured | 3 | 2013 | 1617 | 0.100 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 129 | 0.100 |
Why?
|
| Pneumonia | 1 | 2013 | 60 | 0.100 |
Why?
|
| Aorta | 1 | 2013 | 197 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 3 | 2013 | 1804 | 0.090 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 228 | 0.090 |
Why?
|
| Alkalies | 1 | 2012 | 5 | 0.090 |
Why?
|
| Electric Impedance | 1 | 2012 | 28 | 0.090 |
Why?
|
| Neoplasm Metastasis | 1 | 2013 | 233 | 0.090 |
Why?
|
| Phagocytosis | 1 | 2012 | 83 | 0.090 |
Why?
|
| Cell Line, Tumor | 3 | 2014 | 2598 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 222 | 0.090 |
Why?
|
| Nuclear Proteins | 1 | 2013 | 330 | 0.090 |
Why?
|
| Enzyme Activation | 2 | 2009 | 462 | 0.090 |
Why?
|
| Occupational Exposure | 1 | 2011 | 89 | 0.080 |
Why?
|
| Carcinoma, Bronchogenic | 1 | 2010 | 1 | 0.080 |
Why?
|
| Kinetics | 1 | 2012 | 698 | 0.080 |
Why?
|
| Gene Regulatory Networks | 1 | 2011 | 143 | 0.080 |
Why?
|
| Epithelium | 1 | 2010 | 78 | 0.080 |
Why?
|
| Silicon Dioxide | 1 | 2009 | 38 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2013 | 548 | 0.080 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2009 | 40 | 0.080 |
Why?
|
| Titanium | 1 | 2009 | 46 | 0.080 |
Why?
|
| Particle Size | 1 | 2010 | 267 | 0.070 |
Why?
|
| Mesothelioma | 1 | 2010 | 148 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 1 | 2008 | 506 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 933 | 0.070 |
Why?
|
| Histones | 1 | 2008 | 194 | 0.070 |
Why?
|
| Mice | 3 | 2013 | 6490 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2008 | 884 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2008 | 973 | 0.060 |
Why?
|
| Osteoblasts | 1 | 2003 | 44 | 0.050 |
Why?
|
| Dinoprostone | 1 | 2003 | 69 | 0.050 |
Why?
|
| Estradiol | 1 | 2003 | 269 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 379 | 0.040 |
Why?
|
| Biotransformation | 1 | 2018 | 68 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2013 | 683 | 0.040 |
Why?
|
| Neoplasms | 1 | 2009 | 1341 | 0.040 |
Why?
|
| Female | 3 | 2013 | 24018 | 0.030 |
Why?
|
| Lentivirus | 1 | 2014 | 24 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 188 | 0.030 |
Why?
|
| Markov Chains | 1 | 2013 | 42 | 0.030 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2013 | 54 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2014 | 154 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 2013 | 66 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 165 | 0.020 |
Why?
|
| Surface Properties | 1 | 2013 | 157 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 223 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2012 | 23 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 456 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 366 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2012 | 94 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 438 | 0.020 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2009 | 41 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2012 | 421 | 0.020 |
Why?
|
| Caspases | 1 | 2009 | 148 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2014 | 1420 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2012 | 1729 | 0.020 |
Why?
|
| Apoptosis | 1 | 2014 | 1541 | 0.020 |
Why?
|
| Cell Survival | 1 | 2009 | 934 | 0.020 |
Why?
|
| Aged | 2 | 2012 | 7982 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2012 | 2485 | 0.010 |
Why?
|
| Polyunsaturated Alkamides | 1 | 2003 | 15 | 0.010 |
Why?
|
| Estrogen Antagonists | 1 | 2003 | 29 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2003 | 102 | 0.010 |
Why?
|
| Middle Aged | 2 | 2012 | 11819 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 522 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 649 | 0.010 |
Why?
|
| Adult | 2 | 2012 | 13458 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2003 | 1265 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2003 | 2803 | 0.010 |
Why?
|